US equities |
MU $1,029.00 ▼-0.66% NVDA $229.28 ▼-0.52% SPCX $162.57 ▲+1.25% TSLA $382.70 ▲+2.05% AAPL $336.64 ▼-1.11% MSFT $535.07 ▲+2.38% AMZN $262.43 ▲+3.29% META $718.67 ▼-0.31%
FinancialContent

Latest News about Kabir Nath

Recent news which mentions Kabir Nath

As Psilocybin Trials Face Delays, Compass Pathways (CMPS) Cuts Workforce To Conserve Cash
Tickers CMPS NEWS
Tags Kabir Nath Cannabis Teri Loxam
From Benzinga
EXCLUSIVE: AMA Moves Toward Psychedelic Therapy Reimbursement, Filing A Gap In Regulations
Tickers CMPS JNJ
Tags Markets MDMA treatment Market News
From Benzinga
COMPASS Pathways Shares Q3 2022 Financial Results, Business News & Term's Highlights
Tickers CMPS
Tags Market News Guidance Management
From Benzinga
Compass Pathways Reports Q2 Financial Results, R&D Expenses Keep Growing
Tickers CMPS
Tags Earnings Psychedelics Markets
From Benzinga
Psychedelics Management Updates: Two Top Companies Appoint New CEOs, Here's What We Know
Tickers BMY CMPS DMTTF GS
Tags Benzinga OTSKF News
From Benzinga